Targeting linacs for new hadron-therapy treatment modes
CERN-MEDICIS has produced its first radioisotopes for medical research
Proton and ion therapy set to transform global cancer treatment
Working towards medical linacs for challenging environments
ENLIGHT: 15 years of promoting hadron therapy in Europe
Knowledge transfer has become an established part of CERN’s programme, says Frédérick Bordry.
Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications (AAA), a spin-off radiopharmaceutical firm established by former CERN physicist Stefano Buono in 200...
The core mission of CERN is fundamental research in particle physics. Yet, as a publicly funded laboratory, it also has a remit to ensure that its technology and expertise deliver prompt and tangible ...
We want to build a culture of entrepreneurship whereby more people leaving CERN consider starting a business, says Knowledge Transfer head Giovanni Anelli.
Heike Kamerlingh Onnes won his Nobel prize back in 1913 two years after the discovery of superconductivity; Georg Bednorz and Alexander Müller won theirs in 1987, just a year after discovering high-t...